MADISON, Wis.–(BUSINESS WIRE)–Silatronix® has been awarded a $10.1 million contract from the U.S. Navy Office of Naval Research (ONR). The contract, entitled “Organosilicon Electrolytes for Safe, High Energy, High-Nickel NMC Li-ion Batteries” will focus on the use of Organosilicon (OS) electrolytes to improve the cycling stability of Li-ion cells using NMC622 and NMC811 cathode materials in combination with various state-of-the-art anode materials. This ONR project leverages Silatronix® substantial expertise in the development of new OS based solvents for Li-ion battery applications, and the Company’s world class, Li-ion battery materials evaluation laboratory and analysis capability.
JANESVILLE, Wis., Aug. 9, 2019 – SHINE Medical Technologies LLC today announced it has received a $15-million award from the Department of Energy’s National Nuclear Security Administration (DOE/NNSA). The award was made by the agency as part of its effort to establish a reliable, U.S.-produced supply of molybdenum-99 (Mo-99), the most commonly used medical isotope, without the use of highly enriched uranium.
Many companies developing artificial intelligence software for healthcare are trying to improve doctors’ ability to diagnose disease. Fewer emerging healthcare AI businesses are focused on what happens after a diagnosis, aiming to figure out how treatments are working.
July 22nd, 2019 – JANESVILLE, WI – SHINE Medical Technologies LLC today announced that the company has filed an application with the U.S. Nuclear Regulatory Commission to produce medical isotopes, including molybdenum-99 (Mo-99), iodine-131 and xenon-133, at its production facility in Janesville, WI.
MINNEAPOLIS–(BUSINESS WIRE)–POPS! Diabetes Care—a revolutionary diabetes care management company—is excited to announce that it has closed an oversubscribed Series A funding round of $6 million USD due to strong investor demand.
ANESVILLE, Wis., June 19, 2019 /PRNewswire/ — Phoenix, LLC, a Madison, WI nuclear technology company, and SHINE Medical Technologies, a Janesville, WI medical isotope production company, today announced completion of a 132-hour test of the high-flux Phoenix neutron generator that will drive SHINE’s medical isotope production system. This is a vital milestone in proving out the performance and reliability of Phoenix’s neutron generator technology and SHINE’s medical isotope production process.
Phoenix Neutron Generator Completes Milestone Validating Output and Reliability June 19th, 2019 – Janesville, WI – SHINE Medical Technologies, a Janesville, WI medical isotope production company, announced the completion of an important milestone validating the SHINE...
SWALLOW SOLUTIONS – Investors in La Crosse have revived hopes for a medical device, invented in Madison, aimed at helping people who have swallowing disorders.
Production Facility Groundbreaking May 9th, 2019 – Janesville, WI – SHINE Medical Technologies, Inc. (SHINE), a Wisconsin company dedicated to being the world leader in the safe, clean, affordable production of medical isotopes, broke ground today on their first...
Novel Separation Method Accelerates SHINE’s Path to Market for Cancer Treatment Isotopes May 15th, 2019 – Prague, Czechia – SHINE Medical Technologies, Inc. (SHINE), a Wisconsin company dedicated to being the world leader in the safe, clean, affordable production of...